Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

From function to structure: Cortical thickness correlates of olfactory dysfunction across cognitively normal, mild cognitive impairment and Parkinson's disease.

Decreased olfactory function occurs in over half of individuals aged 65-80 years, and in 62-80% of those over 80 years of age. Hyposmia is an early symptom and a potential marker for a number of neurodegenerative diseases, including Parkinson's disease (PD) and Alzheimer's disease (AD), and can predict the conversion from Mild Cognitive Impairment (MCI) to AD. Building on our previously published resting-state fMRI findings on olfactory network functional connectivity [10], this study examined the same 74 participants categorized as Cognitively Normal (CN), MCI, or PD with cognitive impairment (PD-CogImp) using the Brief Smell Identification Test (B-SIT®). Automated measurements of cortical thickness (CT) and volume for 34 bilateral cortical regions were obtained using FreeSurfer v7.3.2. A moderation analysis based on multiple linear regression was performed to investigate the relationship between B-SIT® scores and cortical measures, controlling for age, education, sex, APOE genotype, and estimated total intracranial volume (eTIV). A significant interaction effect of clinical diagnosis on the olfaction-cortical thickness relationship was identified in 3 out of 68 regions of interest (ROIs): the cuneus bilaterally and the right pericalcarine gyrus, all showing large effect sizes (η2 > 0.14). CN individuals showed a significant positive association between B-SIT® and CT in these regions, whereas MCI and PD-CogImp groups showed a negative trend. Cortical volume models yielded no significant findings after correction for multiple comparisons. These results highlight distinct diagnostic group-specific patterns in the olfaction-brain structure relationship, with implications for understanding early pathological aging and neurodegeneration.

P. Giriprakash, J. Caldwell, R. L. Doty et al. · 0 citations